Copyright: ©Author(s) 2026.
World J Clin Oncol. Aug 24, 2026; 17(8): 123375
Published online Aug 24, 2026. doi: 10.5306/wjco.123375
Published online Aug 24, 2026. doi: 10.5306/wjco.123375
Table 2 Quantitative outcomes reported in studies of near-complete clinical response after neoadjuvant therapy in rectal cancer
| Ref. | nCR rate | cCR rate | nCR → cCR conversion | Local regrowth (nCR vs cCR) | Distant metastasis | Organ preservation (nCR vs cCR) |
| Rosen et al[17], 2025 | 15% (189/1230) | 32% (395/1230) | - | 40% vs 24%1 | 48% vs 17%2 (OR: 4.59) | 53% vs 73% |
| Hupkens et al[11], 2018 | 40% (68/170) | 60% (102/170) | 90% (44/49) | 27% vs 16%3 | - | Sustained W&W4 |
| Verheij et al[7], 2024 | - | - | - | 94% < 2 years5 | - | Approximately 50% (overall) |
- Citation: Tantinam T, Bhatanaprabhabhan K, Ngamsirimas B, Sutharat P, Thiengthiantham R, Santrakul N, Sanmee S, Supatrakul E, Chandrachamnong P, Buakhrun S. Near-complete clinical response after neoadjuvant therapy in rectal cancer: Decision-making between organ preservation and surgery. World J Clin Oncol 2026; 17(8): 123375
- URL: https://www.wjgnet.com/2218-4333/full/v17/i8/123375.htm
- DOI: https://dx.doi.org/10.5306/wjco.123375